AngioDynamics (ANGO)

12.20 -0.13  -1.05%  May 25, 11:00PM Go Pro
Watch this stock

AngioDynamics Tangible Common Equity Ratio: 85.50%

Get Interactive Chart for

View ANGO Tangible Common Equity Ratio with YCharts Pro.




Start My 14-Day Free Trial We respect your privacy. We will never share your email address.
document.write('');

Access these YCharts Pro features:

  • Export any data you want
  • Save any chart as an image
  • Utilize advanced screener power
  • View 30 years of financial history
  • over 90 advanced calculations
  • Enjoy an advertising free experience
and much more...

ANGO Tangible Common Equity Ratio Rankings

Overall 6th percentile 4108 of 4385
Sector 11th percentile 445 of 504 in Healthcare
Industry 14th percentile 55 of 64 in Medical Instruments & Supplies

ANGO Tangible Common Equity Ratio Range, Past 5 Years

Minimum 69.65% May 2008
Maximum 87.68% Aug 2010
Average 81.77%

About Tangible Common Equity Ratio

The tangible common equity (TCE) ratio is a useful number to gauge leverage of a financial firm. Specifically, it answers the question: "How much can the value of a bank's assets fall before the entire value of tangible* common equity is wiped out?"

For example, assume a bank as a TCE ratio of 5%. If the value of all of the banks assets fell by 5%, theoretically stockholders would no longer have a claim on the bank's tangible assets.

Another way of thinking about the TCE ratio of 5% is that the remaining 95% of the bank's tangible assets have been purchased using loaned funds that the bank must repay.

This ratio is worth spending time with. Once investors understand its implications, they rarely look at banking businesses the same way.

* The word tangible, in accounting, essentially means anything that can be touched or traded. Cash, buildings, accounts receivable, inventories and stock holdings of a business are all tangible assets. Trade secrets, patents, copyrights, and goodwill are not tangible assets, even though they may have value.
Learn More

ANGO News

AngioDynamics Completes Acquisition of Navilyst Medical http://stks.co/3vuI $ANGO
about 5 days ago by evcgroup
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition http://stks.co/3qGr $ANGO
about 12 days ago by evcgroup
RT @MedDevice ABC on Dr. Cunningham of @VeinClinics on the VenaCure 1470 for varicose veins bit.ly/VeinClinicsofAmericaBrentwood $ANGO
about 20 days ago by evcgroup
$ANGO filed latest Quarterly Report http://stks.co/3GyA
about 48 days ago by MarketBrief
$ANGO New 52 Week Low - Crossed daily lows support.
about 48 days ago by TradeIdeasQuant
AngioDynamics Goes Red
Apr 09, 12:00PM Fool
Listen to $ANGO Q3 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3E55
about 53 days ago by earningscast
AngioDynamics Receives FDA Clearance for NeverTouch Direct Procedure Kit to be Used With VenaCure EVLT System http://stks.co/2OQd $ANGO
about 103 days ago by evcgroup
AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter http://stks.co/2InF $ANGO
about 109 days ago by evcgroup
$ANGO 200 Day SMA Cross - Price crossed below 200 day SMA (14.4842). Confirmed by volume.
about 117 days ago by TradeIdeasQuant
$ANGO Q3 adj-EPS from 9-11c to 7-9c, Q4 from 11-13c to 10-12c, FY12 from 41-45c to 38-42c
about 124 days ago by Street_Insider
$ANGO shares sink: cuts Q3, Q4, FY12 guidance
about 124 days ago by Street_Insider
$ANGO filed latest Quarterly Report http://stks.co/1ocw
about 142 days ago by MarketBrief
$ANGO filed latest Quarterly Report http://stks.co/1nMi
about 143 days ago by MarketBrief
Listen to $ANGO Q2 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/1nIm
about 143 days ago by earningscast
$ANGO Reports Q2 EPS $0.09 vs $0.12 Est; Revenues $58.10M vs $56.26M Est
about 143 days ago by Benzinga
AngioDynamics' new VenaCure 1470 in Houston http://stks.co/1PWW $ANGO
about 173 days ago by evcgroup
Listen to $ANGO at piper jaffray health care conference - live at 03:00 PM, ondemand after - http://stks.co/1KNG
about 179 days ago by earningscast
AngioDynamics Expands Senior Leadership Team $ANGO http://stks.co/11Gy
about 201 days ago by evcgroup
RT @EVCGroup RT @MedDevice Here's where varicose vein treatment is today, a solid summary in Vascular Disease Management goo.gl/j3Vk1 $ANGO
about 205 days ago by evcgroup
$ANGO filed latest Quarterly Report http://stks.co/ZxW
about 229 days ago by MarketBrief
$ANGO Reports Q1 EPS $0.08 vs $0.08 Est; Revenue $54.4M vs $53.86M Est; Announces Stock Repurchase Authorization of up to $20M
about 234 days ago by Benzinga
AngioDynamics $ANGO shares falling as FDA issues warning letter over NY plant inspection
about 271 days ago by Street_Insider
$NEOP Big Hedge funds need 2 buy & drive it up to $9,see how much Martin can lose! $CMN,$CALP,$ANGO,$OSUR,$DNDN,$PFE,$TEVA,$MRK,$JNJ,$NVS
about 355 days ago by funkybunch
After falling about 3% before the Nasdaq could halt, shares of $ANGO have bounced upon resumption, now down about 1.2% from today's close.
about 488 days ago by Street_Insider

Recent Quotes

Symbol Price Chg Chg % Market Cap
ANGO 12.20 -0.13 -1.05% 306.46M
ANGN 5.85 +0.20 +3.54% 22.93M
ANF 36.23 +0.94 +2.66% 3.069B
ANEN 19.05 +0.06 +0.32% 283.65M
ASPS 57.98 -1.04 -1.76% 1.352B
ASP 11.61 -0.05 -0.46%
ASNA 18.90 -0.02 -0.11% 2.896B
ASML 46.00 -0.22 -0.48% 19.03B
ASMI 35.28 -0.28 -0.79% 1.954B
ASM 1.24 -0.01 -0.72% 25.52M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close